Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ab0947d66370d3a49ea2b47eb74050c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-46 |
filingDate |
2017-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f02e7417d41f49127e610f273a1dcff4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eb046c370cf8c04c3f46d6953deae7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce39d8e44105ccc5ff357133c8d2e276 |
publicationDate |
2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10208096-B2 |
titleOfInvention |
Function suppression type of genetically-modified rhodocytin mutant |
abstract |
According to the present invention, a mutant rhodocytin lacking platelet aggregation ability is provided. According to the present invention, a pharmaceutical composition including a mutant rhodocytin lacking platelet aggregation ability is provided. According to the present invention, there is provided a method for inhibiting platelet aggregation by a platelet aggregating substance, including administering a pharmaceutical composition including a mutant rhodocytin lacking platelet aggregation ability to a subject in need thereof. |
priorityDate |
2016-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |